Citizens Maintains Market Outperform on Evolent Health, Lowers Price Target to $10

Benzinga · 3d ago
Citizens analyst Constantine Davides maintains Evolent Health (NYSE:EVH) with a Market Outperform and lowers the price target from $11 to $10.